Vertex Pharmaceuticals · 1 month ago
Vertex Summer Intern 2026, Clinical and Quantitative Pharmacology
Boston, MA
Internship
Hybrid
Intern
$33/hr - $50/hr
Start in 2026 SpringVertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. They are seeking a summer intern for their Clinical and Quantitative Pharmacology program, which offers hands-on experience in drug development, allowing interns to work on meaningful projects and gain insights from industry leaders.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
U.S. Citizen Only
Responsibilities
Research literature, published studies, and regulatory guidance
Learn to work with and manipulate clinical data and data constructs
Analyses of data collected from literature or clinical trial PK and/or PK/PD data in NONMEM, R and/or related software
Summarize the main findings
Prepare presentation(s) for various internal forums
Qualification
Required
Enrolled in a PhD or PharmD program in pharmacology, or a related field of study by Fall 2025
Communicate clearly through verbal and written communication
Understanding of drug metabolism, PK, and PK/PD principles
Legal authorization to work in the United States, now and in the future
You must be available to work full-time, 40 hours per week from May – August 2026
Preferred
Knowledge of protein therapeutics
Quantitative and hands-on skills
PK and/or PK/PD analyses
Experience with data analysis tools such as R, Phoenix WinNonlin, NONMEM or other programming/software applications
Prior industry experience
Benefits
Free 24/7 onsite gym access and free access to group exercise classes
Subsidized commuter benefits- transit and parking
Provided meals—free breakfast daily!
Career development opportunities and events, including C Suite engagement
Social events—both intern-only and company-wide
Location-specific perks and extras!
Recognition of National Intern Day
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Founded in 1989
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-05
2026-01-05
Company data provided by crunchbase